Mahmoud Mansour

2.2k total citations
62 papers, 1.8k citations indexed

About

Mahmoud Mansour is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mahmoud Mansour has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mahmoud Mansour's work include Nigella sativa pharmacological applications (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). Mahmoud Mansour is often cited by papers focused on Nigella sativa pharmacological applications (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). Mahmoud Mansour collaborates with scholars based in Saudi Arabia, Egypt and United States. Mahmoud Mansour's co-authors include Mahmoud N. Nagi, Aiman S. El‐Khatib, Othman A. Al‐Shabanah, Abdullah M. Al‐Bekairi, Susanne Tornhamre, Hassan A. El‐Kashef, Leif Stenke, Peter Reizenstein, Hesham M. Korashy and Mohamed M. Sayed‐Ahmed and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Mahmoud Mansour

52 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud Mansour Saudi Arabia 20 834 391 358 320 302 62 1.8k
Mohamed M. Sayed‐Ahmed Saudi Arabia 29 384 0.5× 334 0.9× 372 1.0× 132 0.4× 784 2.6× 48 2.3k
Ghada M. Suddеk Egypt 28 259 0.3× 268 0.7× 238 0.7× 89 0.3× 546 1.8× 77 1.8k
El‐Shaimaa A. Arafa Egypt 25 266 0.3× 275 0.7× 303 0.8× 136 0.4× 789 2.6× 63 2.1k
Dayun Sui China 25 304 0.4× 361 0.9× 145 0.4× 80 0.3× 1.2k 3.9× 96 1.8k
Dharamvir Singh Arya India 23 684 0.8× 244 0.6× 343 1.0× 36 0.1× 561 1.9× 47 1.9k
Hamid Mollazadeh Iran 26 362 0.4× 266 0.7× 147 0.4× 52 0.2× 663 2.2× 49 2.0k
Dina S. El‐Agamy Egypt 23 194 0.2× 304 0.8× 237 0.7× 58 0.2× 470 1.6× 60 1.5k
Yoosik Yoon South Korea 29 235 0.3× 120 0.3× 132 0.4× 125 0.4× 948 3.1× 85 2.0k
Shi-Bing Su China 30 428 0.5× 563 1.4× 140 0.4× 51 0.2× 1.3k 4.3× 125 2.9k
Li‐Hua Lian China 31 264 0.3× 540 1.4× 324 0.9× 55 0.2× 1.0k 3.4× 96 2.4k

Countries citing papers authored by Mahmoud Mansour

Since Specialization
Citations

This map shows the geographic impact of Mahmoud Mansour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Mansour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Mansour more than expected).

Fields of papers citing papers by Mahmoud Mansour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Mansour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Mansour. The network helps show where Mahmoud Mansour may publish in the future.

Co-authorship network of co-authors of Mahmoud Mansour

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Mansour. A scholar is included among the top collaborators of Mahmoud Mansour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Mansour. Mahmoud Mansour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Mansour, Mahmoud, et al.. (2024). Colistin induced neurotoxicity with bulbar palsy. A case report and literature review. IDCases. 38. e02116–e02116.
4.
Mansour, Mahmoud, et al.. (2023). FATAL MYOCARDITIS TWO WEEKS AFTER IMMUNE CHECK POINT INHIBITOR THERAPY INITIATION: A CASE REPORT. Journal of the American College of Cardiology. 81(8). 3571–3571.
5.
Alkatheri, Abdulmalik, et al.. (2016). Comparison of the effectiveness of equal doses of short and long-acting erythrocyte stimulating agents for managing anemia in chronic kidney disease adult patients. International Journal of Medical Research & Health Sciences. 5(12). 335–342. 2 indexed citations
6.
Mansour, Mahmoud, et al.. (2014). Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma. Chemico-Biological Interactions. 215. 17–24. 13 indexed citations
7.
Albekairy, Abdulkareem, Abdulmalik Alkatheri, & Mahmoud Mansour. (2013). Inhibition of ubiquitin-proteasome pathway: A possible treatment of hepatocellular carcinoma. International Journal of Medicine and Medical Sciences. 5(6). 312–319. 2 indexed citations
8.
Alkatheri, Abdulmalik, Abdulkareem Albekairy, & Mahmoud Mansour. (2013). Diabetic Retinopathy: Its Progression and the Effective Treatment to Prevent Blindness. Pharmacologia. 4(2). 138–156. 1 indexed citations
10.
Bachelot, Anne, Kathleen Laborde, Geneviève Plu‐Bureau, et al.. (2007). Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism. Journal of Endocrinological Investigation. 30(8). 636–646. 11 indexed citations
11.
Nampoory, M.R.N., K.V. Johny, Tarek Said, et al.. (2005). The Area Under the Concentration-Time Curve Versus Trough and Peak Blood Level Monitoring in Renal Transplant Recipients on Cyclosporine. Transplantation Proceedings. 37(7). 3019–3021. 3 indexed citations
12.
Mansour, Mahmoud & Susanne Tornhamre. (2004). Inhibition of 5-lipoxygenase and Leukotriene C4Synthase in Human Blood Cells by Thymoquinone. Journal of Enzyme Inhibition and Medicinal Chemistry. 19(5). 431–436. 101 indexed citations
13.
Mansour, Mahmoud, Ayman M. Gamal El-Din, Mahmoud N. Nagi, Othman A. Al‐Shabanah, & Abdullah M. Al‐Bekairi. (2003). Nω-Nitro-L-Arginine Methylester Ameliorates Myocardial Toxicity Induced by Doxorubicin. BMB Reports. 36(6). 593–596. 8 indexed citations
14.
Mansour, Mahmoud, et al.. (2002). Protective effect of l -arginine against nephrotoxicity induced by cyclosporine in normal rats. Pharmacological Research. 45(6). 441–446. 29 indexed citations
15.
Al‐Majed, Abdulhakeem A., et al.. (2002). ALPHA-LIPOIC ACID AMELIORATES MYOCARDIAL TOXICITY INDUCED BY DOXORUBICIN. Pharmacological Research. 46(6). 499–503. 34 indexed citations
16.
Mansour, Mahmoud, et al.. (2002). The Beneficial Interaction Between Enalapril and Danazol in Normal Rat. Scientia Pharmaceutica. 70(2). 165–175. 1 indexed citations
17.
Mansour, Mahmoud, et al.. (2001). Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone.. PubMed. 110(3-4). 239–51. 154 indexed citations
18.
Mansour, Mahmoud, et al.. (2000). Transvaginal Ultrasonographic Cervical Assessment as a Predictor Of Successful Labor Induction. The Egyptian Journal of Hospital Medicine. 1(1). 48–59. 2 indexed citations
19.
Agha, Azza M. & Mahmoud Mansour. (2000). Effects of Captopril on Interleukin-6, Leukotriene B4, and Oxidative Stress Markers in Serum and Inflammatory Exudate of Arthritic Rats: Evidence of Antiinflammatory Activity. Toxicology and Applied Pharmacology. 168(2). 123–130. 37 indexed citations
20.
El-Ahmady, O., et al.. (1997). Elevated Concentrations of Interleukins and Leukotriene in Response to Mycobacterium Tuberculosis Infection. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(2). 160–164. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026